Global Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Region: Trend Forecast and Growth Opportunity
Global biopharmaceuticals market will reach $1,001.1 billion by 2033, growing by 8.8% annually over 2023-2033. The growth is driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical trials and approvals for novel biomedicines, escalating healthcare spending, and favorable reimbursement policies.
Highlighted with 78 tables and 119 figures, this 215-page report “Global Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global biopharmaceuticals market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify the global biopharmaceuticals market in every aspect of the classification from perspectives of Product Type, Testing Service, Raw Material, Classification, Therapeutic Area, and Region.
Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Monoclonal Antibodies
o Anti-cancer Monoclonal Antibodies
o Anti-inflammatory Monoclonal Antibodies
o Other Monoclonal Antibodies
• Recombinant Growth Factors
o Erythropoietin
o Granulocyte Colony Stimulating Factor
• Purified Proteins
o Leukemia Inhibitory Factor (LIF)
o P53 Protein
o P38 Protein
o Other Purified Proteins
• Recombinant Proteins
o Serum Albumin
o Amyloid Protein
o Defensin
o Transferrin
• Recombinant Hormones
o Recombinant Human Growth Hormones
o Recombinant Insulin
o Other Recombinant Hormones
• Vaccines
o Recombinant Vaccines
Cancer Vaccines
Malaria Vaccines
Ebola Vaccines
Hepatitis Vaccines
Tetanus Vaccines
Diphtheria Vaccines
Cholera Vaccines
Other Recombinant Vaccines
o Conventional Vaccines
Polio Vaccines
Pox Vaccines
Other Conventional Vaccines
• Recombinant Enzymes
o Enterokinase
o Cyclase
o Caspase
o Cathepsin
• Cell and Gene Therapies
o Allogenic Products
o Autologous Products
o Acellular Products
• Synthetic Immunomodulators
• Other Product Types
o Blood Factors
o Other Products
Based on Testing Service, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Laboratory Testing
• Custom Testing/Customer Proprietary Testing
• Compendial and Multi Compendial Laboratory Testing
By Raw Material, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Formulation Excipients
• Active Pharmaceutical Ingredients (API)
• Other Materials
By Classification, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Innovative Biopharmaceuticals
• Biogenerics and Biosimilars
By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Oncology
• Inflammatory and Infectious Diseases
• Autoimmune Disorders
• Metabolic Disorders
• Hormonal Disorders
• Cardiovascular Diseases
• Neurological Diseases
• Other Therapeutic Areas
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
For each region and country, detailed analysis and annual revenue ($ mn) are available for 2023-2033. The breakdown of all regional markets by country and the breakdown of each national market by Product Type and Therapeutic Area over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Amgen Inc.
Astrazeneca PLC
Bayer AG
Biogen Inc.
Bristol-myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Novo Nordisk As
Pfizer Inc.
Sanofi Sa
Sharp Packaging Services
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals
WuXi AppTec
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 11
1.1 Industry Definition and Research Scope 11
1.1.1 Industry Definition 11
1.1.2 Research Scope 12
1.2 Research Methodology 15
1.2.1 Overview of Market Research Methodology 15
1.2.2 Market Assumption 16
1.2.3 Secondary Data 16
1.2.4 Primary Data 16
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 28
2.1.3 Impact of Russia-Ukraine Conflict 30
2.1.4 Impact of Israel-Palestine War 32
2.2 Major Growth Drivers 33
2.3 Market Restraints and Challenges 42
2.4 Emerging Opportunities and Market Trends 45
2.5 Porter’s Fiver Forces Analysis 49
3 Segmentation of Global Market by Product Type 53
3.1 Market Overview by Product Type 53
3.2 Monoclonal Antibodies 55
3.2.1 Anti-cancer Monoclonal Antibodies 56
3.2.2 Anti-inflammatory Monoclonal Antibodies 57
3.2.3 Other Monoclonal Antibodies 58
3.3 Recombinant Growth Factors 59
3.3.1 Erythropoietin 60
3.3.2 Granulocyte Colony Stimulating Factor 61
3.4 Purified Proteins 62
3.4.1 Leukemia Inhibitory Factor (LIF) 63
3.4.2 P53 Protein 64
3.4.3 P38 Protein 65
3.4.4 Other Purified Proteins 66
3.5 Recombinant Proteins 67
3.5.1 Serum Albumin 68
3.5.2 Amyloid Protein 69
3.5.3 Defensin 70
3.5.4 Transferrin 71
3.6 Recombinant Hormones 72
3.6.1 Recombinant Human Growth Hormones 73
3.6.2 Recombinant Insulin 75
3.6.3 Other Recombinant Hormones 76
3.7 Vaccines 77
3.7.1 Recombinant Vaccines 78
3.7.2 Conventional Vaccines 80
3.8 Recombinant Enzymes 81
3.8.1 Enterokinase 82
3.8.2 Cyclase 83
3.8.3 Caspase 84
3.8.4 Cathepsin 85
3.9 Cell and Gene Therapies 86
3.9.1 Allogenic Products 87
3.9.2 Autologous Products 88
3.9.3 Acellular Products 89
3.10 Synthetic Immunomodulators 90
3.11 Other Product Types 91
3.11.1 Blood Factors 92
3.11.2 Other Products 93
4 Segmentation of Global Market by Testing Service 94
4.1 Market Overview by Testing Service 94
4.2 Laboratory Testing 96
4.3 Custom Testing/Customer Proprietary Testing 97
4.4 Compendial and Multi Compendial Laboratory Testing 98
5 Segmentation of Global Market by Raw Material 99
5.1 Market Overview by Raw Material 99
5.2 Formulation Excipients 101
5.3 Active Pharmaceutical Ingredients (API) 102
5.4 Other Materials 103
6 Segmentation of Global Market by Classification 104
6.1 Market Overview by Classification 104
6.2 Innovative Biopharmaceuticals 106
6.3 Biogenerics and Biosimilars 107
7 Segmentation of Global Market by Therapeutic Area 108
7.1 Market Overview by Therapeutic Area 108
7.2 Oncology 110
7.3 Inflammatory and Infectious Diseases 111
7.4 Autoimmune Disorders 112
7.5 Metabolic Disorders 113
7.6 Hormonal Disorders 114
7.7 Cardiovascular Diseases 115
7.8 Neurological Diseases 116
7.9 Other Therapeutic Areas 117
8 Segmentation of Global Market by Region 118
8.1 Geographic Market Overview 2023-2033 118
8.2 North America Market 2023-2033 by Country 122
8.2.1 Overview of North America Market 122
8.2.2 U.S. 126
8.2.3 Canada 129
8.2.4 Mexico 131
8.3 European Market 2023-2033 by Country 133
8.3.1 Overview of European Market 133
8.3.2 Germany 137
8.3.3 U.K. 139
8.3.4 France 141
8.3.5 Spain 143
8.3.6 Italy 145
8.3.7 Netherlands 147
8.3.8 Rest of European Market 149
8.4 Asia-Pacific Market 2023-2033 by Country 151
8.4.1 Overview of Asia-Pacific Market 151
8.4.2 Japan 155
8.4.3 China 158
8.4.4 Australia 160
8.4.5 India 162
8.4.6 South Korea 164
8.4.7 Rest of APAC Region 166
8.5 South America Market 2023-2033 by Country 168
8.5.1 Argentina 171
8.5.2 Brazil 173
8.5.3 Chile 175
8.5.4 Rest of South America Market 177
8.6 MEA Market 2023-2033 by Country 178
8.6.1 UAE 181
8.6.2 Saudi Arabia 183
8.6.3 South Africa 185
8.6.4 Other National Markets 187
9 Competitive Landscape 188
9.1 Overview of Key Vendors 188
9.2 New Product Launch, Partnership, Investment, and M&A 192
9.3 Company Profiles 193
Abbott Laboratories 193
Amgen Inc. 195
Astrazeneca PLC 196
Bayer AG 197
Biogen Inc. 198
Bristol-myers Squibb Company (BMS) 199
Eli Lilly and Company 200
F. Hoffmann-La Roche Ltd. 201
Glaxosmithkline PLC 202
Johnson & Johnson 203
Merck & Co. Inc. 204
Novartis Ag 205
Novo Nordisk As 206
Pfizer Inc. 207
Sanofi Sa 208
Sharp Packaging Services 209
Sun Pharmaceutical Industries Ltd. 210
Takeda Pharmaceutical Company Limited 211
Thermo Fisher Scientific Inc. 212
Vertex Pharmaceuticals 213
WuXi AppTec 214
RELATED REPORTS 215
List of Tables:
Table 1. Snapshot of Global Biopharmaceuticals Market in Balanced Perspective, 2023-2033 21
Table 2. World Economic Outlook, 2024-2036 25
Table 3. World Economic Outlook, 2022-2024 27
Table 4. Scenarios for Economic Impact of Ukraine Crisis 31
Table 5. Scenarios for Economic Impact of Israel-Palestine War 32
Table 6. World Health Spending by Region, $ bn, 2013-2020 37
Table 7. Total Number of Registered Clinical Studies Worldwide, 2010-2021 38
Table 8. Worldwide Number of New Cancer by Type, 2020 39
Table 9. Main Product Trends and Market Opportunities in Global Biopharmaceuticals Market 45
Table 10. Global Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 53
Table 11. Global Biopharmaceuticals Market: Monoclonal Antibodies by Type, 2023-2033, $ mn 55
Table 12. Global Biopharmaceuticals Market: Recombinant Growth Factor by Type, 2023-2033, $ mn 59
Table 13. Global Biopharmaceuticals Market: Purified Proteins by Type, 2023-2033, $ mn 62
Table 14. Global Biopharmaceuticals Market: Recombinant Proteins by Type, 2023-2033, $ mn 67
Table 15. Global Biopharmaceuticals Market: Recombinant Hormones by Type, 2023-2033, $ mn 72
Table 16. Selected Drugs for COVID-19 Treatment in Development, Nov 2022 74
Table 17. Global Biopharmaceuticals Market: Vaccines by Type, 2023-2033, $ mn 77
Table 18. Global Biopharmaceuticals Market: Recombinant Vaccines by Type, 2023-2033, $ mn 79
Table 19. Global Biopharmaceuticals Market: Conventional Vaccines by Type, 2023-2033, $ mn 80
Table 20. Global Biopharmaceuticals Market: Recombinant Enzymes by Type, 2023-2033, $ mn 81
Table 21. Global Biopharmaceuticals Market: Cell and Gene Therapies by Type, 2023-2033, $ mn 86
Table 22. Global Biopharmaceuticals Market: Other Product Types by Type, 2023-2033, $ mn 91
Table 23. Global Biopharmaceuticals Market by Testing Service, 2023-2033, $ mn 94
Table 24. Global Biopharmaceuticals Market by Raw Material, 2023-2033, $ mn 99
Table 25. Global Biopharmaceuticals Market by Classification, 2023-2033, $ mn 104
Table 26. Global Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 108
Table 27. Global Biopharmaceuticals Market by Region, 2023-2033, $ mn 119
Table 28. Leading National Biopharmaceuticals Market, 2023 and 2033, $ mn 121
Table 29. North America Biopharmaceuticals Market by Country, 2023-2033, $ mn 124
Table 30. U.S. Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 128
Table 31. U.S. Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 128
Table 32. Canada Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 130
Table 33. Canada Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 130
Table 34. Mexico Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 132
Table 35. Mexico Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 132
Table 36. Europe Biopharmaceuticals Market by Country, 2023-2033, $ mn 136
Table 37. Germany Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 138
Table 38. Germany Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 138
Table 39. U.K. Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 140
Table 40. U.K. Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 140
Table 41. France Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 142
Table 42. France Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 142
Table 43. Spain Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 144
Table 44. Spain Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 144
Table 45. Italy Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 146
Table 46. Italy Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 146
Table 47. Netherlands Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 148
Table 48. Netherlands Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 148
Table 49. Biopharmaceuticals Market in Rest of Europe by Country, 2023-2033, $ mn 150
Table 50. APAC Biopharmaceuticals Market by Country, 2023-2033, $ mn 153
Table 51. Japan Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 157
Table 52. Japan Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 157
Table 53. China Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 159
Table 54. China Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 159
Table 55. Australia Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 161
Table 56. Australia Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 161
Table 57. India Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 163
Table 58. India Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 163
Table 59. South Korea Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 165
Table 60. South Korea Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 165
Table 61. Biopharmaceuticals Market in Rest of APAC by Country/Region, 2023-2033, $ mn 167
Table 62. South America Biopharmaceuticals Market by Country, 2023-2033, $ mn 170
Table 63. Argentina Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 172
Table 64. Argentina Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 172
Table 65. Brazil Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 174
Table 66. Brazil Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 174
Table 67. Chile Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 176
Table 68. Chile Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 176
Table 69. MEA Biopharmaceuticals Market by Country, 2023-2033, $ mn 180
Table 70. UAE Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 182
Table 71. UAE Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 182
Table 72. Saudi Arabia Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 184
Table 73. Saudi Arabia Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 184
Table 74. South Africa Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 186
Table 75. South Africa Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 186
Table 76. Abbott Laboratories: Company Snapshot 193
Table 77. Abbott Laboratories: Business Segmentation 194
Table 78. Abbott Laboratories: Product Portfolio 194
List of Figures:
Figure 1. Research Method Flow Chart 15
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 18
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 20
Figure 4. Global Biopharmaceuticals Market, 2023-2033, $ mn 23
Figure 5. Impact of COVID-19 on Business 28
Figure 6. Primary Drivers and Impact Factors of Global Biopharmaceuticals Market 33
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 36
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 36
Figure 9. Worldwide Novel Active Substances (NASs) Launches by Therapeutic Area, 2013-2022 37
Figure 10. Primary Restraints and Impact Factors of Global Biopharmaceuticals Market 42
Figure 11. Investment Opportunity Analysis 46
Figure 12. Porter’s Fiver Forces Analysis of Global Biopharmaceuticals Market 49
Figure 13. Breakdown of Global Biopharmaceuticals Market by Product Type, 2023-2033, % of Revenue 54
Figure 14. Global Addressable Market Cap in 2024-2033 by Product Type, Value ($ mn) and Share (%) 54
Figure 15. Global Biopharmaceuticals Market by Product Type: Monoclonal Antibodies, 2023-2033, $ mn 55
Figure 16. Global Biopharmaceuticals Market by Monoclonal Antibodies: Anti-cancer Monoclonal Antibodies, 2023-2033, $ mn 56
Figure 17. Global Biopharmaceuticals Market by Monoclonal Antibodies: Anti-inflammatory Monoclonal Antibodies, 2023-2033, $ mn 57
Figure 18. Global Biopharmaceuticals Market by Monoclonal Antibodies: Other Monoclonal Antibodies, 2023-2033, $ mn 58
Figure 19. Global Biopharmaceuticals Market by Product Type: Recombinant Growth Factors, 2023-2033, $ mn 59
Figure 20. Global Biopharmaceuticals Market by Recombinant Growth Factor: Erythropoietin, 2023-2033, $ mn 60
Figure 21. Global Biopharmaceuticals Market by Recombinant Growth Factor: Granulocyte Colony Stimulating Factor, 2023-2033, $ mn 61
Figure 22. Global Biopharmaceuticals Market by Product Type: Purified Proteins, 2023-2033, $ mn 62
Figure 23. Global Biopharmaceuticals Market by Purified Proteins: Leukemia Inhibitory Factor (LIF), 2023-2033, $ mn 63
Figure 24. Global Biopharmaceuticals Market by Purified Proteins: P53 Protein, 2023-2033, $ mn 64
Figure 25. Global Biopharmaceuticals Market by Purified Proteins: P38 Protein, 2023-2033, $ mn 65
Figure 26. Global Biopharmaceuticals Market by Purified Proteins: Other Purified Proteins, 2023-2033, $ mn 66
Figure 27. Global Biopharmaceuticals Market by Product Type: Recombinant Proteins, 2023-2033, $ mn 67
Figure 28. Global Biopharmaceuticals Market by Recombinant Proteins: Serum Albumin, 2023-2033, $ mn 68
Figure 29. Global Biopharmaceuticals Market by Recombinant Proteins: Amyloid Protein, 2023-2033, $ mn 69
Figure 30. Global Biopharmaceuticals Market by Recombinant Proteins: Defensin, 2023-2033, $ mn 70
Figure 31. Global Biopharmaceuticals Market by Recombinant Proteins: Transferrin, 2023-2033, $ mn 71
Figure 32. Global Biopharmaceuticals Market by Product Type: Recombinant Hormones, 2023-2033, $ mn 72
Figure 33. Global Biopharmaceuticals Market by Recombinant Hormones: Recombinant Human Growth Hormones, 2023-2033, $ mn 73
Figure 34. Global Biopharmaceuticals Market by Recombinant Hormones: Recombinant Insulin, 2023-2033, $ mn 75
Figure 35. Global Biopharmaceuticals Market by Recombinant Hormones: Other Recombinant Hormones, 2023-2033, $ mn 76
Figure 36. Global Biopharmaceuticals Market by Product Type: Vaccines, 2023-2033, $ mn 77
Figure 37. Global Biopharmaceuticals Market by Vaccines: Recombinant Vaccines, 2023-2033, $ mn 78
Figure 38. Global Biopharmaceuticals Market by Vaccines: Conventional Vaccines, 2023-2033, $ mn 80
Figure 39. Global Biopharmaceuticals Market by Product Type: Recombinant Enzymes, 2023-2033, $ mn 81
Figure 40. Global Biopharmaceuticals Market by Recombinant Enzymes: Enterokinase, 2023-2033, $ mn 82
Figure 41. Global Biopharmaceuticals Market by Recombinant Enzymes: Cyclase, 2023-2033, $ mn 83
Figure 42. Global Biopharmaceuticals Market by Recombinant Enzymes: Caspase, 2023-2033, $ mn 84
Figure 43. Global Biopharmaceuticals Market by Recombinant Enzymes: Cathepsin, 2023-2033, $ mn 85
Figure 44. Global Biopharmaceuticals Market by Product Type: Cell and Gene Therapies, 2023-2033, $ mn 86
Figure 45. Global Biopharmaceuticals Market by Cell and Gene Therapies: Allogenic Products, 2023-2033, $ mn 87
Figure 46. Global Biopharmaceuticals Market by Cell and Gene Therapies: Autologous Products, 2023-2033, $ mn 88
Figure 47. Global Biopharmaceuticals Market by Cell and Gene Therapies: Acellular Products, 2023-2033, $ mn 89
Figure 48. Global Biopharmaceuticals Market by Product Type: Synthetic Immunomodulators, 2023-2033, $ mn 90
Figure 49. Global Biopharmaceuticals Market by Product Type: Other Product Types, 2023-2033, $ mn 91
Figure 50. Global Biopharmaceuticals Market by Other Product Types: Blood Factors, 2023-2033, $ mn 92
Figure 51. Global Biopharmaceuticals Market by Other Product Types: Other Products, 2023-2033, $ mn 93
Figure 52. Breakdown of Global Biopharmaceuticals Market by Testing Service, 2023-2033, % of Sales Revenue 95
Figure 53. Global Addressable Market Cap in 2024-2033 by Testing Service, Value ($ mn) and Share (%) 95
Figure 54. Global Biopharmaceuticals Market by Testing Service: Laboratory Testing, 2023-2033, $ mn 96
Figure 55. Global Biopharmaceuticals Market by Testing Service: Custom Testing/Customer Proprietary Testing, 2023-2033, $ mn 97
Figure 56. Global Biopharmaceuticals Market by Testing Service: Compendial and Multi Compendial Laboratory Testing, 2023-2033, $ mn 98
Figure 57. Breakdown of Global Biopharmaceuticals Market by Raw Material, 2023-2033, % of Sales Revenue 100
Figure 58. Global Addressable Market Cap in 2024-2033 by Raw Material, Value ($ mn) and Share (%) 100
Figure 59. Global Biopharmaceuticals Market by Raw Material: Formulation Excipients, 2023-2033, $ mn 101
Figure 60. Global Biopharmaceuticals Market by Raw Material: Active Pharmaceutical Ingredients (API), 2023-2033, $ mn 102
Figure 61. Global Biopharmaceuticals Market by Raw Material: Other Materials, 2023-2033, $ mn 103
Figure 62. Breakdown of Global Biopharmaceuticals Market by Classification, 2023-2033, % of Revenue 105
Figure 63. Global Addressable Market Cap in 2024-2033 by Classification, Value ($ mn) and Share (%) 105
Figure 64. Global Biopharmaceuticals Market by Classification: Innovative Biopharmaceuticals, 2023-2033, $ mn 106
Figure 65. Global Biopharmaceuticals Market by Classification: Biogenerics and Biosimilars, 2023-2033, $ mn 107
Figure 66. Breakdown of Global Biopharmaceuticals Market by Therapeutic Area, 2023-2033, % of Revenue 109
Figure 67. Global Addressable Market Cap in 2024-2033 by Therapeutic Area, Value ($ mn) and Share (%) 109
Figure 68. Global Biopharmaceuticals Market by Therapeutic Area: Oncology, 2023-2033, $ mn 110
Figure 69. Global Biopharmaceuticals Market by Therapeutic Area: Inflammatory and Infectious Diseases, 2023-2033, $ mn 111
Figure 70. Global Biopharmaceuticals Market by Therapeutic Area: Autoimmune Disorders, 2023-2033, $ mn 112
Figure 71. Global Biopharmaceuticals Market by Therapeutic Area: Metabolic Disorders, 2023-2033, $ mn 113
Figure 72. Global Biopharmaceuticals Market by Therapeutic Area: Hormonal Disorders, 2023-2033, $ mn 114
Figure 73. Global Biopharmaceuticals Market by Therapeutic Area: Cardiovascular Diseases, 2023-2033, $ mn 115
Figure 74. Global Biopharmaceuticals Market by Therapeutic Area: Neurological Diseases, 2023-2033, $ mn 116
Figure 75. Global Biopharmaceuticals Market by Therapeutic Area: Other Therapeutic Areas, 2023-2033, $ mn 117
Figure 76. Global Market Snapshot by Region 118
Figure 77. Geographic Spread of Worldwide Biopharmaceuticals Market, 2023-2033, % of Sales Revenue 119
Figure 78. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%) 120
Figure 79. North American Biopharmaceuticals Market, 2023-2033, $ mn 123
Figure 80. Breakdown of North America Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 124
Figure 81. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 125
Figure 82. U.S. Biopharmaceuticals Market, 2023-2033, $ mn 127
Figure 83. Venture Capital Deal Activity and Investment Flows in the U.S., 2013-2022, $ bn and Deal Counts 127
Figure 84. Canada Biopharmaceuticals Market, 2023-2033, $ mn 129
Figure 85. Biopharmaceuticals Market in Mexico, 2023-2033, $ mn 131
Figure 86. European Biopharmaceuticals Market, 2023-2033, $ mn 134
Figure 87. Breakdown of European Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 135
Figure 88. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 136
Figure 89. Biopharmaceuticals Market in Germany, 2023-2033, $ mn 137
Figure 90. Biopharmaceuticals Market in U.K., 2023-2033, $ mn 139
Figure 91. Biopharmaceuticals Market in France, 2023-2033, $ mn 141
Figure 92. Biopharmaceuticals Market in Spain, 2023-2033, $ mn 143
Figure 93. Biopharmaceuticals Market in Italy, 2023-2033, $ mn 145
Figure 94. Biopharmaceuticals Market in Netherlands, 2023-2033, $ mn 147
Figure 95. Biopharmaceuticals Market in Rest of Europe, 2023-2033, $ mn 149
Figure 96. Asia-Pacific Biopharmaceuticals Market, 2023-2033, $ mn 152
Figure 97. Breakdown of APAC Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 152
Figure 98. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 154
Figure 99. Biopharmaceuticals Market in Japan, 2023-2033, $ mn 156
Figure 100. Biopharmaceuticals Market in China, 2023-2033, $ mn 158
Figure 101. Biopharmaceuticals Market in Australia, 2023-2033, $ mn 160
Figure 102. Biopharmaceuticals Market in India, 2023-2033, $ mn 162
Figure 103. Biopharmaceuticals Market in South Korea, 2023-2033, $ mn 164
Figure 104. Biopharmaceuticals Market in Rest of APAC, 2023-2033, $ mn 166
Figure 105. South America Biopharmaceuticals Market, 2023-2033, $ mn 169
Figure 106. Breakdown of South America Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 169
Figure 107. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 170
Figure 108. Biopharmaceuticals Market in Argentina, 2023-2033, $ mn 171
Figure 109. Biopharmaceuticals Market in Brazil, 2023-2033, $ mn 173
Figure 110. Biopharmaceuticals Market in Chile, 2023-2033, $ mn 175
Figure 111. Biopharmaceuticals Market in Rest of South America, 2023-2033, $ mn 177
Figure 112. Biopharmaceuticals Market in Middle East and Africa (MEA), 2023-2033, $ mn 179
Figure 113. Breakdown of MEA Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 179
Figure 114. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 180
Figure 115. Biopharmaceuticals Market in UAE, 2023-2033, $ mn 181
Figure 116. Biopharmaceuticals Market in Saudi Arabia, 2023-2033, $ mn 183
Figure 117. Biopharmaceuticals Market in South Africa, 2023-2033, $ mn 185
Figure 118. Growth Stage of Global Biopharmaceuticals Industry over the Forecast Period 188
Figure 119. Worldwide Top Ten Best-selling Biotech Drugs in 2022, $ bn 190
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|